MedImmune Ventures, Inc. is 10% Owner at G1 Therapeutics, Inc. (GTHX). They have made 8 open-market trades across 4 companies since 2014, most recently 2017-12-15.
CIK 0001291884
5 open-market purchases totalling $8.3M since 2014, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GTHX | SELL | 2017-12-15 | 2017-12-18 | $19.75 | $4.0M | -2.6% | +17.8% | +84.2% |
| GTHX | SELL | 2017-12-01 | 2017-12-05 | $19.75 | $5.3M | +3.0% | +4.5% | +37.7% |
| GTHX | SELL | 2017-11-20 | 2017-11-22 | $20.01 | $8.0M | -8.6% | -6.7% | -8.3% |
| GTHX | BUY | 2017-05-22 | 2017-05-24 | $15.00 | $1.1M | +8.4% | +5.4% | +2.3% |
| GTHX | BUY | 2017-05-17 | 2017-12-13 | $15.00 | $1.1M | -2.9% | +15.0% | +93.4% |
| CATB | BUY | 2015-06-30 | 2015-06-30 | $12.00 | $2.7M | N/A | N/A | N/A |
| ITEK | BUY | 2015-02-23 | 2015-02-25 | $6.00 | $2.5M | -29.1% | +4.1% | +4.1% |
| AGTC | BUY | 2014-04-01 | 2014-04-01 | $12.00 | $909K | -27.2% | -1.3% | -1.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.